Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (71-80 of 397) with videos related to

Pageof 40
Sort By:
BMC Infectious Diseases|September 26, 2020
HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protectionPeter Vickerman, Matthew Quaife, Maggie Kilbourne-Brook, et al.
Addiction (Abingdon, England)|October 17, 2009
If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculationsMatt Hickman, Peter Vickerman, John Macleod, et al.
The International Journal on Drug Policy|February 17, 2024
Trends and factors associated with illicit drug use in South Africa: Findings from multiple national population-based household surveys, 2002-2017Kennedy Kipkoech Mutai, Jack Stone, Andrew Scheibe, et al.
Addiction (Abingdon, England)|January 21, 2017
Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?Ilias Gountas, Vana Sypsa, Olga Anagnostou, et al.
BMC Medicine|August 21, 2015
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatmentsNick Scott, Emma McBryde, Peter Vickerman, et al.
AIDS and Behavior|October 4, 2023
Associations Between Sexual Behavior Stigma and HIV Risk Behaviors, Testing, Treatment, and Infection Among Men Who have Sex with Men in UkraineBen Alvey, Jack Stone, Tetyana Salyuk, et al.
Scientific Reports|March 20, 2021
Discovering environmental management opportunities for infectious disease controlLudovica Beltrame, Hannah Rose Vineer, Josephine G Walker, et al.
Contraception|December 8, 2010
Apples and oranges? Interpreting success in HIV prevention trialsLori L Heise, Charlotte Watts, Anna Foss, et al.
International Journal of Epidemiology|June 13, 2017
Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impactLouis MacGregor, Natasha K Martin, Christinah Mukandavire, et al.
Sexually Transmitted Diseases|February 15, 2011
The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South AfricaPeter Vickerman, Angela Devine, Anna M Foss, et al.
Pageof 40

Showing results (71-80 of 397) with videos related to

Sort By:
Pageof 40
BMC Infectious Diseases|September 26, 2020
HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protectionPeter Vickerman, Matthew Quaife, Maggie Kilbourne-Brook, et al.
Addiction (Abingdon, England)|October 17, 2009
If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculationsMatt Hickman, Peter Vickerman, John Macleod, et al.
The International Journal on Drug Policy|February 17, 2024
Trends and factors associated with illicit drug use in South Africa: Findings from multiple national population-based household surveys, 2002-2017Kennedy Kipkoech Mutai, Jack Stone, Andrew Scheibe, et al.
Addiction (Abingdon, England)|January 21, 2017
Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?Ilias Gountas, Vana Sypsa, Olga Anagnostou, et al.
BMC Medicine|August 21, 2015
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatmentsNick Scott, Emma McBryde, Peter Vickerman, et al.
AIDS and Behavior|October 4, 2023
Associations Between Sexual Behavior Stigma and HIV Risk Behaviors, Testing, Treatment, and Infection Among Men Who have Sex with Men in UkraineBen Alvey, Jack Stone, Tetyana Salyuk, et al.
Scientific Reports|March 20, 2021
Discovering environmental management opportunities for infectious disease controlLudovica Beltrame, Hannah Rose Vineer, Josephine G Walker, et al.
Contraception|December 8, 2010
Apples and oranges? Interpreting success in HIV prevention trialsLori L Heise, Charlotte Watts, Anna Foss, et al.
International Journal of Epidemiology|June 13, 2017
Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impactLouis MacGregor, Natasha K Martin, Christinah Mukandavire, et al.
Sexually Transmitted Diseases|February 15, 2011
The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South AfricaPeter Vickerman, Angela Devine, Anna M Foss, et al.
Pageof 40